Saudi Arabia launches biological samples to space station
Samples sent to International Space Station as part of research programme on neurodegenerative diseases.
At a glance
- Biological samples launched to the International Space Station as part of BioGravity-1 mission
- Research aims to study cellular changes linked to ageing and neurodegenerative diseases
- Programme involves international partnership with US organisations and NASA support
- First phase sends reference human samples from healthy donors to establish scientific baseline
Saudi Arabia has launched biological samples to the International Space Station aboard SpaceX CRS-35 as part of the BioGravity-1 mission, according to the Saudi Space Agency and King Abdullah University of Science and Technology. The samples represent the first of their kind launched from the Middle East, with support from NASA.
The mission is the first phase of a long-term research programme studying cellular changes associated with ageing and neurodegenerative diseases, including Alzheimer's disease and multiple sclerosis. The programme involves an international partnership with the US-based National Stem Cell Foundation and Axiom Space, alongside participation from Saudi institutions.
Why it matters
The mission expands the Kingdom's involvement in microgravity research and demonstrates the application of space science to health and life sciences research through international collaboration.
Original reporting
- Saudi Gazette — LatestSaudi Arabia launches first biological samples of their kind from Middle East to space
- Saudi GazetteSaudi Arabia launches first biological samples of their kind from Middle East to space
- Asharq Al-Awsat (English)Saudi Arabia Launches First Biological Samples from the Middle East to Space
This brief was written with AI assistance from the reports listed above and checked against our editorial policy. Spotted an error? Request a correction.